Tumor-associated antigens (TAAs) are proteins that are expressed by tumor cells and can be recognized by the immune system. TAAs can be used to develop cancer vaccines and immunotherapies. TAAs can be classified into several categories including differentiation antigens, cancer-testis antigens, overexpressed antigens, mutated antigens, and viral antigens.
Tumor-associated antigens
- Erlotinib HCl (OSI-744), Epidermal growth factor receptor erbB1 inhibitor
Cas#:183319-69-9
Starting at $64.90